Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Creative Medical Technology Holdings, Inc. (CELZ : NSDQ)

• Company Description    Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX. Number of Employees: 4

• Price / Volume Information    Yesterday's Closing Price: $1.96 Daily Weekly Monthly 20 Day Moving Average: 74,558 shares Shares Outstanding: 2.58 (millions) Market Capitalization: $5.06 (millions) Beta: 2.08 52 Week High: $6.90 52 Week Low: $1.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.71% -11.56% 12 Week -44.36% -45.26% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 211 E. OSBORN ROAD - PHOENIX,AZ 85012 USA ph: 480-399-2822 fax: - dsullivan@equityny.com http://www.creativemedicaltechnology.com

• General Corporate Information    Officers Timothy Warbington - Chief Executive Officer and Chairman Donald Dickerson - Chief Financial Officer Bruce S. Urdang - Director Michael H. Finger - Director Susan Snow - Director Peer Information Creative Medical Technology Holdings, Inc. (CORR.) Creative Medical Technology Holdings, Inc. (RSPI) Creative Medical Technology Holdings, Inc. (CGXP) Creative Medical Technology Holdings, Inc. (BGEN) Creative Medical Technology Holdings, Inc. (GTBP) Creative Medical Technology Holdings, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 22529Y408 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/13/26 Share - Related Items Shares Outstanding: 2.58 Most Recent Split Date: 6.00 (0.10:1) Beta: 2.08 Market Capitalization: $5.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.37 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.40 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.90 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 36.00% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 0.00% ROE 12/31/25 - - 09/30/25 - -88.90 06/30/25 - -82.99 ROA 12/31/25 - - 09/30/25 - -85.24 06/30/25 - -79.49 Current Ratio 12/31/25 - - 09/30/25 - 20.74 06/30/25 - 23.86 Quick Ratio 12/31/25 - - 09/30/25 - 20.73 06/30/25 - 23.86 Operating Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Net Margin 12/31/25 - - 09/30/25 - - 06/30/25 - - Pre-Tax Margin 12/31/25 - - 09/30/25 - -99,333.34 06/30/25 - -96,066.66 Book Value 12/31/25 - - 09/30/25 - 2.17 06/30/25 - 2.64 Inventory Turnover 12/31/25 - - 09/30/25 - 1.85 06/30/25 - 1.27 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©